Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...
The Honda NT1100 has been a roaring success since its debut in 2023. Markets like Europe and Asia’s in particular have really ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback